Search research articles
Contact Us
Filters
Showing results (111-120 of 119) with videos related to
Page
of 12
Sort By:
You have reached the last page of results.
This site can display upto 119 results.
Frontiers in Oncology
|
October 3, 2022
Comparative kinase and cancer cell panel profiling of kinase inhibitors approved for clinical use from 2018 to 2020
Jeffrey J Kooijman, Wilhelmina E van Riel, Jelle Dylus, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 15, 2010
Fragment-based discovery of 6-substituted isoquinolin-1-amine based ROCK-I inhibitors
Peter Ray, Jane Wright, Julia Adam, et al.
Leukemia
|
May 19, 2021
MAPK-ERK is a central pathway in T-cell acute lymphoblastic leukemia that drives steroid resistance
Jordy C G van der Zwet, Jessica G C A M Buijs-Gladdines, Valentina Cordo', et al.
The FEBS Journal
|
January 20, 2021
Pharmacological validation of TDO as a target for Parkinson's disease
Paula Perez-Pardo, Yvonne Grobben, Nicole Willemsen-Seegers, et al.
Frontiers in Immunology
|
February 15, 2021
Targeting Indoleamine 2,3-Dioxygenase in Cancer Models Using the Novel Small Molecule Inhibitor NTRC 3883-0
Yvonne Grobben, Jos de Man, Antoon M van Doornmalen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 9, 2015
Inhibition of the spindle assembly checkpoint kinase TTK enhances the efficacy of docetaxel in a triple-negative breast cancer model
A R R Maia, J de Man, U Boon, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 19, 2014
Chemokine cooperativity is caused by competitive glycosaminoglycan binding
Folkert Verkaar, Jody van Offenbeek, Miranda M C van der Lee, et al.
Journal of Medicinal Chemistry
|
May 9, 2012
A prospective cross-screening study on G-protein-coupled receptors: lessons learned in virtual compound library design
Marijn P A Sanders, Luc Roumen, Eelke van der Horst, et al.
Nature Communications
|
January 16, 2024
Selective CK1α degraders exert antiproliferative activity against a broad range of human cancer cell lines
Gisele Nishiguchi, Lauren G Mascibroda, Sarah M Young, et al.
Page
of 12
Search research articles
Search
Showing results (111-120 of 119) with videos related to
Sort By:
Page
of 12
You have reached the last page of results.
This site can display upto 119 results.
Frontiers in Oncology
|
October 3, 2022
Comparative kinase and cancer cell panel profiling of kinase inhibitors approved for clinical use from 2018 to 2020
Jeffrey J Kooijman, Wilhelmina E van Riel, Jelle Dylus, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 15, 2010
Fragment-based discovery of 6-substituted isoquinolin-1-amine based ROCK-I inhibitors
Peter Ray, Jane Wright, Julia Adam, et al.
Leukemia
|
May 19, 2021
MAPK-ERK is a central pathway in T-cell acute lymphoblastic leukemia that drives steroid resistance
Jordy C G van der Zwet, Jessica G C A M Buijs-Gladdines, Valentina Cordo', et al.
The FEBS Journal
|
January 20, 2021
Pharmacological validation of TDO as a target for Parkinson's disease
Paula Perez-Pardo, Yvonne Grobben, Nicole Willemsen-Seegers, et al.
Frontiers in Immunology
|
February 15, 2021
Targeting Indoleamine 2,3-Dioxygenase in Cancer Models Using the Novel Small Molecule Inhibitor NTRC 3883-0
Yvonne Grobben, Jos de Man, Antoon M van Doornmalen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 9, 2015
Inhibition of the spindle assembly checkpoint kinase TTK enhances the efficacy of docetaxel in a triple-negative breast cancer model
A R R Maia, J de Man, U Boon, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 19, 2014
Chemokine cooperativity is caused by competitive glycosaminoglycan binding
Folkert Verkaar, Jody van Offenbeek, Miranda M C van der Lee, et al.
Journal of Medicinal Chemistry
|
May 9, 2012
A prospective cross-screening study on G-protein-coupled receptors: lessons learned in virtual compound library design
Marijn P A Sanders, Luc Roumen, Eelke van der Horst, et al.
Nature Communications
|
January 16, 2024
Selective CK1α degraders exert antiproliferative activity against a broad range of human cancer cell lines
Gisele Nishiguchi, Lauren G Mascibroda, Sarah M Young, et al.
Page
of 12